Artemis Investment Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Artemis Investment Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-108,464	Closed	-$1.33M	–	244
2016 Q4	$1.33M	Hold	108,464	–	–	0.04%	195
2016 Q3	$1.28M	Hold	108,464	–	–	0.04%	183
2016 Q2	$943K	Hold	108,464	–	–	0.03%	208
2016 Q1	$571K	Sell	108,464 -108	-0.1%	-$601	0.01%	216
2015 Q4	$843K	Hold	108,572	–	–	0.02%	191
2015 Q3	$853K	Hold	108,572	–	–	0.03%	198
2015 Q2	$984K	Hold	108,572	–	–	0.03%	183
2015 Q1	$1.41M	Hold	108,572	–	–	0.06%	183
2014 Q4	$1.48M	Hold	108,572	–	–	0.06%	177
2014 Q3	$974K	Buy	+108,572	New	+$1.17M	0.05%	164

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artemis Investment Management's GNMK Position: Q1 2017 in Review

Artemis Investment Management sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2017, closing a stake of 108,464 shares — an estimated $1.33M sold.

Artemis Investment Management first reported a position in GNMK in Q3 2014 and held it in 10 quarters. The position peaked at $1.48M in Q4 2014. 86 funds tracked by Wall St. Rank hold GNMK as of Q1 2017.

Artemis Investment Management reported no remaining GenMark Diagnostics, Inc position as of Q1 2017 after selling out during the quarter.
Artemis Investment Management sold 108,464 GenMark Diagnostics, Inc shares in Q1 2017, an estimated $1.33M.
Artemis Investment Management first reported a position in GenMark Diagnostics, Inc in Q3 2014 and held it in 10 quarters.
Artemis Investment Management's GenMark Diagnostics, Inc position peaked at $1.48M in Q4 2014.
86 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2017.

Based on Artemis Investment Management's 13F filing for Q1 2017, filed 12 May 2017.